{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:18:12Z","timestamp":1791569892999,"version":"4.3.4"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T00:00:00Z","timestamp":1561075200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T00:00:00Z","timestamp":1561075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1038\/s41584-019-0243-5","type":"journal-article","created":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T14:02:46Z","timestamp":1561125766000},"page":"491-501","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":133,"title":["Systemic effects of IL-17 in inflammatory arthritis"],"prefix":"10.1038","volume":"15","author":[{"given":"Audrey","family":"Beringer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3280-6346","authenticated-orcid":false,"given":"Pierre","family":"Miossec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,21]]},"reference":[{"key":"243_CR1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrrheum.2011.75","volume":"7","author":"DPM Symmons","year":"2011","unstructured":"Symmons, D. P. M. & Gabriel, S. E. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat. Rev. Rheumatol. 7, 399\u2013408 (2011).","journal-title":"Nat. Rev. Rheumatol."},{"key":"243_CR2","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrcardio.2014.206","volume":"12","author":"M Prasad","year":"2015","unstructured":"Prasad, M. et al. Cardiorheumatology: cardiac involvement in systemic rheumatic disease. Nat. Rev. Cardiol. 12, 168\u2013176 (2015).","journal-title":"Nat. Rev. Cardiol."},{"key":"243_CR3","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.ahj.2013.07.010","volume":"166","author":"CS Crowson","year":"2013","unstructured":"Crowson, C. S. et al. Rheumatoid arthritis and cardiovascular disease. Am. Heart J. 166, 622\u2013628 (2013).","journal-title":"Am. Heart J."},{"key":"243_CR4","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.molmed.2016.01.001","volume":"22","author":"A Beringer","year":"2016","unstructured":"Beringer, A., Noack, M. & Miossec, P. IL-17 in chronic inflammation: from discovery to targeting. Trends Mol. Med. 22, 230\u2013241 (2016).","journal-title":"Trends Mol. Med."},{"key":"243_CR5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrrheum.2015.53","volume":"11","author":"E Lubberts","year":"2015","unstructured":"Lubberts, E. The IL-23-IL-17 axis in inflammatory arthritis. Nat. Rev. Rheumatol. 11, 415\u2013429 (2015).","journal-title":"Nat. Rev. Rheumatol."},{"key":"243_CR6","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nri2586","volume":"9","author":"SL Gaffen","year":"2009","unstructured":"Gaffen, S. L. Structure and signalling in the IL-17 receptor family. Nat. Rev. Immunol. 9, 556\u2013567 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"243_CR7","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3389\/fmed.2018.00364","volume":"5","author":"M Robert","year":"2019","unstructured":"Robert, M. & Miossec, P. IL-17 in rheumatoid arthritis and precision medicine: from synovitis expression to circulating bioactive levels. Front. Med. 5, 364 (2019).","journal-title":"Front. Med."},{"key":"243_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1365-2567.2009.03240.x","volume":"129","author":"RM Onishi","year":"2010","unstructured":"Onishi, R. M. & Gaffen, S. L. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 129, 311\u2013321 (2010).","journal-title":"Immunology"},{"key":"243_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1084\/jem.20061738","volume":"204","author":"MA Kleinschek","year":"2007","unstructured":"Kleinschek, M. A. et al. IL-25 regulates Th17 function in autoimmune inflammation. J. Exp. Med. 204, 161\u2013170 (2007).","journal-title":"J. Exp. Med."},{"key":"243_CR10","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3389\/fimmu.2017.00647","volume":"8","author":"F Lavocat","year":"2017","unstructured":"Lavocat, F., Ndongo-Thiam, N. & Miossec, P. Interleukin-25 produced by synoviocytes has anti-inflammatory effects by acting as a receptor antagonist for interleukin-17A function. Front. Immunol. 8, 647 (2017).","journal-title":"Front. Immunol."},{"key":"243_CR11","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nri2800","volume":"10","author":"DJ Cua","year":"2010","unstructured":"Cua, D. J. & Tato, C. M. Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 10, 479\u2013489 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"243_CR12","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nri3707","volume":"14","author":"SL Gaffen","year":"2014","unstructured":"Gaffen, S. L., Jain, R., Garg, A. V. & Cua, D. J. The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat. Rev. Immunol. 14, 585\u2013600 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"243_CR13","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1002\/art.33507","volume":"64","author":"TJ Kenna","year":"2012","unstructured":"Kenna, T. J. et al. Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive \u03b3\/\u03b4 T cells in patients with active ankylosing spondylitis. Arthritis Rheum. 64, 1420\u20131429 (2012).","journal-title":"Arthritis Rheum."},{"key":"243_CR14","first-page":"425","volume":"5","author":"B Osta","year":"2014","unstructured":"Osta, B., Lavocat, F., Eljaafari, A. & Miossec, P. Effects of interleukin-17A on osteogenic differentiation of isolated human mesenchymal stem cells. Front. Immunol. 5, 425 (2014).","journal-title":"Front. Immunol."},{"key":"243_CR15","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.4049\/jimmunol.179.6.4135","volume":"179","author":"J Hartupee","year":"2007","unstructured":"Hartupee, J., Liu, C., Novotny, M., Li, X. & Hamilton, T. IL-17 enhances chemokine gene expression through mRNA stabilization. J. Immunol. 179, 4135\u20134141 (2007).","journal-title":"J. Immunol."},{"key":"243_CR16","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.jss.2013.03.025","volume":"183","author":"M Hara","year":"2013","unstructured":"Hara, M. et al. Interleukin-17A plays a pivotal role in cholestatic liver fibrosis in mice. J. Surg. Res. 183, 574\u2013582 (2013).","journal-title":"J. Surg. Res."},{"key":"243_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-11-226","volume":"11","author":"T Sparna","year":"2010","unstructured":"Sparna, T. et al. Genome-wide comparison between IL-17 and combined TNF-alpha\/IL-17 induced genes in primary murine hepatocytes. BMC Genomics 11, 226 (2010).","journal-title":"BMC Genomics"},{"key":"243_CR18","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E","volume":"42","author":"M Chabaud","year":"1999","unstructured":"Chabaud, M. et al. Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 42, 963\u2013970 (1999).","journal-title":"Arthritis Rheum."},{"key":"243_CR19","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1002\/art.27622","volume":"62","author":"J Leipe","year":"2010","unstructured":"Leipe, J. et al. Role of Th17 cells in human autoimmune arthritis. Arthritis Rheum. 62, 2876\u20132885 (2010).","journal-title":"Arthritis Rheum."},{"key":"243_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s11010-011-1036-6","volume":"359","author":"SP Raychaudhuri","year":"2012","unstructured":"Raychaudhuri, S. P., Raychaudhuri, S. K. & Genovese, M. C. IL-17 receptor and its functional significance in psoriatic arthritis. Mol. Cell. Biochem. 359, 419\u2013429 (2012).","journal-title":"Mol. Cell. Biochem."},{"key":"243_CR21","doi-asserted-by":"publisher","first-page":"436067","DOI":"10.1155\/2015\/436067","volume":"2015","author":"T Hattori","year":"2015","unstructured":"Hattori, T. et al. Gene expression profiling of IL-17A-treated synovial fibroblasts from the human temporomandibular joint. Mediators Inflamm. 2015, 436067 (2015).","journal-title":"Mediators Inflamm."},{"key":"243_CR22","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1186\/ar4179","volume":"15","author":"S-Y Lee","year":"2013","unstructured":"Lee, S.-Y. et al. IL-17-mediated Bcl-2 expression regulates survival of fibroblast-like synoviocytes in rheumatoid arthritis through STAT3 activation. Arthritis Res. Ther. 15, R31 (2013).","journal-title":"Arthritis Res. Ther."},{"key":"243_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013416","volume":"5","author":"M-L Toh","year":"2010","unstructured":"Toh, M.-L. et al. Role of interleukin 17 in arthritis chronicity through survival of synoviocytes via regulation of synoviolin expression. PLOS ONE 5, e13416 (2010).","journal-title":"PLOS ONE"},{"key":"243_CR24","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3389\/fimmu.2016.00254","volume":"7","author":"G Benedetti","year":"2016","unstructured":"Benedetti, G., Bonaventura, P., Lavocat, F. & Miossec, P. IL-17A and TNF-\u03b1 increase the expression of the antiapoptotic adhesion molecule amigo-2 in arthritis synoviocytes. Front. Immunol. 7, 254 (2016).","journal-title":"Front. Immunol."},{"key":"243_CR25","first-page":"515","volume":"35","author":"S Agarwal","year":"2008","unstructured":"Agarwal, S., Misra, R. & Aggarwal, A. Interleukin 17 levels are increased in juvenile idiopathic arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metalloproteinases. J. Rheumatol. 35, 515\u2013519 (2008).","journal-title":"J. Rheumatol."},{"key":"243_CR26","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1002\/art.21342","volume":"52","author":"MI Koenders","year":"2005","unstructured":"Koenders, M. I. et al. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis. Arthritis Rheum. 52, 3239\u20133247 (2005).","journal-title":"Arthritis Rheum."},{"key":"243_CR27","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41584-018-0091-8","volume":"14","author":"EM Gravallese","year":"2018","unstructured":"Gravallese, E. M. & Schett, G. Effects of the IL-23-IL-17 pathway on bone in spondyloarthritis. Nat. Rev. Rheumatol. 14, 631\u2013640 (2018).","journal-title":"Nat. Rev. Rheumatol."},{"key":"243_CR28","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/art.20001","volume":"50","author":"E Lubberts","year":"2004","unstructured":"Lubberts, E. et al. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum. 50, 650\u2013659 (2004).","journal-title":"Arthritis Rheum."},{"key":"243_CR29","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/ar2936","volume":"12","author":"IE Adamopoulos","year":"2010","unstructured":"Adamopoulos, I. E. et al. Interleukin-17A upregulates receptor activator of NF-\u03baB on osteoclast precursors. Arthritis Res. Ther. 12, R29 (2010).","journal-title":"Arthritis Res. Ther."},{"key":"243_CR30","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/apm.12467","volume":"123","author":"L Yang","year":"2015","unstructured":"Yang, L., Zhang, J., Tao, J. & Lu, T. Elevated serum levels of interleukin-37 are associated with inflammatory cytokines and disease activity in rheumatoid arthritis. APMIS 123, 1025\u20131031 (2015).","journal-title":"APMIS"},{"key":"243_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejr.2015.01.001","volume":"38","author":"HM Al-Saadany","year":"2016","unstructured":"Al-Saadany, H. M., Hussein, M. S., Gaber, R. A. & Zaytoun, H. A. Th-17 cells and serum IL-17 in rheumatoid arthritis patients: Correlation with disease activity and severity. Egypt. Rheumatol. 38, 1\u20137 (2016).","journal-title":"Egypt. Rheumatol."},{"key":"243_CR32","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/cei.12167","volume":"174","author":"NJ Gullick","year":"2013","unstructured":"Gullick, N. J. et al. Enhanced and persistent levels of interleukin (IL)-17+ CD4+ T cells and serum IL-17 in patients with early inflammatory arthritis. Clin. Exp. Immunol. 174, 292\u2013301 (2013).","journal-title":"Clin. Exp. Immunol."},{"key":"243_CR33","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1136\/postgradmedj-2016-134637","volume":"93","author":"YH Lee","year":"2017","unstructured":"Lee, Y. H. & Bae, S.-C. Associations between circulating IL-17 levels and rheumatoid arthritis and between IL-17 gene polymorphisms and disease susceptibility: a meta-analysis. Postgrad. Med. J. 93, 465\u2013471 (2017).","journal-title":"Postgrad. Med. J."},{"key":"243_CR34","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10067-010-1647-4","volume":"30","author":"Y Mei","year":"2011","unstructured":"Mei, Y. et al. Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis. Clin. Rheumatol. 30, 269\u2013273 (2011).","journal-title":"Clin. Rheumatol."},{"key":"243_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012516","volume":"5","author":"NJ Gullick","year":"2010","unstructured":"Gullick, N. J. et al. Linking power doppler ultrasound to the presence of Th17 cells in the rheumatoid arthritis joint. PLOS ONE 5, e12516 (2010).","journal-title":"PLOS ONE"},{"key":"243_CR36","doi-asserted-by":"publisher","first-page":"R126","DOI":"10.1186\/ar3431","volume":"13","author":"D-Y Chen","year":"2011","unstructured":"Chen, D.-Y. et al. Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-\u03b1 therapy. Arthritis Res. Ther. 13, R126 (2011).","journal-title":"Arthritis Res. Ther."},{"key":"243_CR37","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1007\/s00296-011-1995-7","volume":"32","author":"A Taylan","year":"2012","unstructured":"Taylan, A. et al. Evaluation of the T helper 17 axis in ankylosing spondylitis. Rheumatol. Int. 32, 2511\u20132515 (2012).","journal-title":"Rheumatol. Int."},{"key":"243_CR38","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jcma.2012.05.006","volume":"75","author":"W-S Chen","year":"2012","unstructured":"Chen, W.-S. et al. Association of serum interleukin-17 and interleukin-23 levels with disease activity in Chinese patients with ankylosing spondylitis. J. Chin. Med. Assoc. 75, 303\u2013308 (2012).","journal-title":"J. Chin. Med. Assoc."},{"key":"243_CR39","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s00296-009-0883-x","volume":"29","author":"X Wang","year":"2009","unstructured":"Wang, X., Lin, Z., Wei, Q., Jiang, Y. & Gu, J. Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis. Rheumatol. Int. 29, 1343\u20131347 (2009).","journal-title":"Rheumatol. Int."},{"key":"243_CR40","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1136\/annrheumdis-2014-207110","volume":"74","author":"N Ndongo-Thiam","year":"2015","unstructured":"Ndongo-Thiam, N. & Miossec, P. A cell-based bioassay for circulating bioactive IL-17: application to destruction in rheumatoid arthritis. Ann. Rheum. Dis. 74, 1629\u20131631 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"243_CR41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3109\/s10165-007-0015-y","volume":"18","author":"M Kohno","year":"2008","unstructured":"Kohno, M. et al. Interleukin-17 gene expression in patients with rheumatoid arthritis. Mod. Rheumatol. 18, 15\u201322 (2008).","journal-title":"Mod. Rheumatol."},{"key":"243_CR42","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1002\/art.24568","volume":"60","author":"H Shen","year":"2009","unstructured":"Shen, H., Goodall, J. C. & Hill Gaston, J. S. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum. 60, 1647\u20131656 (2009).","journal-title":"Arthritis Rheum."},{"key":"243_CR43","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/art.23291","volume":"58","author":"K Nistala","year":"2008","unstructured":"Nistala, K. et al. Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis Rheum. 58, 875\u2013887 (2008).","journal-title":"Arthritis Rheum."},{"key":"243_CR44","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1161\/ATVBAHA.114.303567","volume":"35","author":"S Taleb","year":"2015","unstructured":"Taleb, S., Tedgui, A. & Mallat, Z. IL-17 and Th17 cells in atherosclerosis: subtle and contextual roles. Arterioscler. Thromb. Vasc. Biol. 35, 258\u2013264 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"243_CR45","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.autrev.2017.07.009","volume":"16","author":"M Robert","year":"2017","unstructured":"Robert, M. & Miossec, P. Effects of interleukin 17 on the cardiovascular system. Autoimmun. Rev. 16, 984\u2013991 (2017).","journal-title":"Autoimmun. Rev."},{"key":"243_CR46","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1084\/jem.183.6.2593","volume":"183","author":"F Fossiez","year":"1996","unstructured":"Fossiez, F. et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183, 2593\u20132603 (1996).","journal-title":"J. Exp. Med."},{"key":"243_CR47","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1159\/000430197","volume":"36","author":"S Yuan","year":"2015","unstructured":"Yuan, S. et al. Interleukin-17 stimulates STAT3-mediated endothelial cell activation for neutrophil recruitment. Cell. Physiol. Biochem. 36, 2340\u20132356 (2015).","journal-title":"Cell. Physiol. Biochem."},{"key":"243_CR48","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.4049\/jimmunol.1400181","volume":"193","author":"C Erbel","year":"2014","unstructured":"Erbel, C. et al. IL-17A influences essential functions of the monocyte\/macrophage lineage and is involved in advanced murine and human atherosclerosis. J.\u00a0Immunol. 193, 4344\u20134355 (2014).","journal-title":"J. Immunol."},{"key":"243_CR49","doi-asserted-by":"publisher","first-page":"8167","DOI":"10.4049\/jimmunol.0901126","volume":"183","author":"C Erbel","year":"2009","unstructured":"Erbel, C. et al. Inhibition of IL-17A attenuates atherosclerotic lesion development in ApoE-deficient mice. J. Immunol. 183, 8167\u20138175 (2009).","journal-title":"J. Immunol."},{"key":"243_CR50","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.108.827618","volume":"119","author":"RE Eid","year":"2009","unstructured":"Eid, R. E. et al. Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 119, 1424\u20131432 (2009).","journal-title":"Circulation"},{"key":"243_CR51","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1136\/annrheumdis-2011-200468","volume":"71","author":"A Hot","year":"2012","unstructured":"Hot, A., Lenief, V. & Miossec, P. Combination of IL-17 and TNF\u03b1 induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells. Ann. Rheum. Dis. 71, 768\u2013776 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"243_CR52","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.clim.2011.07.003","volume":"141","author":"F Zhu","year":"2011","unstructured":"Zhu, F. et al. IL-17 induces apoptosis of vascular endothelial cells: a potential mechanism for human acute coronary syndrome. Clin. Immunol. 141, 152\u2013160 (2011).","journal-title":"Clin. Immunol."},{"key":"243_CR53","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.bbrc.2011.04.080","volume":"408","author":"F Maione","year":"2011","unstructured":"Maione, F. et al. IL-17A increases ADP-induced platelet aggregation. Biochem. Biophys. Res. Commun. 408, 658\u2013662 (2011).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"243_CR54","doi-asserted-by":"publisher","first-page":"196ra100","DOI":"10.1126\/scitranslmed.3006133","volume":"5","author":"A Gister\u00e5","year":"2013","unstructured":"Gister\u00e5, A. et al. Transforming growth factor-\u03b2 signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway. Sci. Transl Med. 5, 196ra100 (2013).","journal-title":"Sci. Transl Med."},{"key":"243_CR55","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1161\/CIRCULATIONAHA.109.924886","volume":"121","author":"E Smith","year":"2010","unstructured":"Smith, E. et al. Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Circulation 121, 1746\u20131755 (2010).","journal-title":"Circulation"},{"key":"243_CR56","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.4049\/jimmunol.1000116","volume":"185","author":"Q Gao","year":"2010","unstructured":"Gao, Q. et al. A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice. J. Immunol. 185, 5820\u20135827 (2010).","journal-title":"J. Immunol."},{"key":"243_CR57","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.atherosclerosis.2010.12.034","volume":"215","author":"X Cheng","year":"2011","unstructured":"Cheng, X. et al. Inhibition of IL-17A in atherosclerosis. Atherosclerosis 215, 471\u2013474 (2011).","journal-title":"Atherosclerosis"},{"key":"243_CR58","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1161\/ATVBAHA.111.227629","volume":"31","author":"MS Madhur","year":"2011","unstructured":"Madhur, M. S. et al. Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 31, 1565\u20131572 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"243_CR59","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1161\/ATVBAHA.111.229997","volume":"32","author":"K Danzaki","year":"2012","unstructured":"Danzaki, K. et al. Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 32, 273\u2013280 (2012).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"243_CR60","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1084\/jem.20090545","volume":"206","author":"S Taleb","year":"2009","unstructured":"Taleb, S. et al. Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J. Exp. Med. 206, 2067\u20132077 (2009).","journal-title":"J. Exp. Med."},{"key":"243_CR61","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12944-016-0402-5","volume":"16","author":"YT Lee","year":"2017","unstructured":"Lee, Y. T. et al. Mouse models of atherosclerosis: a historical perspective and recent advances. Lipids Health Dis. 16, 12 (2017).","journal-title":"Lipids Health Dis."},{"key":"243_CR62","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jacc.2011.10.863","volume":"59","author":"Y-H Liao","year":"2012","unstructured":"Liao, Y.-H. et al. Interleukin-17A contributes to myocardial ischemia\/reperfusion injury by regulating cardiomyocyte apoptosis and neutrophil infiltration. J. Am. Coll. Cardiol. 59, 420\u2013429 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"243_CR63","volume":"1","author":"X Yan","year":"2012","unstructured":"Yan, X. et al. Deleterious effect of the IL-23\/IL-17A axis and \u03b3\u03b4T cells on left ventricular remodeling after myocardial infarction. J. Am. Heart Assoc. 1, e004408 (2012).","journal-title":"J. Am. Heart Assoc."},{"key":"243_CR64","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00109-014-1176-8","volume":"92","author":"S-F Zhou","year":"2014","unstructured":"Zhou, S.-F. et al. IL-17A promotes ventricular remodeling after myocardial infarction. J. Mol. Med. 92, 1105\u20131116 (2014).","journal-title":"J. Mol. Med."},{"key":"243_CR65","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1161\/HYPERTENSIONAHA.112.199265","volume":"60","author":"L Mark\u00f3","year":"2012","unstructured":"Mark\u00f3, L. et al. Interferon-\u03b3 signaling inhibition ameliorates angiotensin II-induced cardiac damage. Hypertension 60, 1430\u20131436 (2012).","journal-title":"Hypertension"},{"key":"243_CR66","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.109.145094","volume":"55","author":"MS Madhur","year":"2010","unstructured":"Madhur, M. S. et al. Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension 55, 500\u2013507 (2010).","journal-title":"Hypertension"},{"key":"243_CR67","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1161\/CIRCRESAHA.114.302157","volume":"114","author":"J Wu","year":"2014","unstructured":"Wu, J. et al. Inflammation and mechanical stretch promote aortic stiffening in hypertension through activation of p38 mitogen-activated protein kinase. Circ. Res. 114, 616\u2013625 (2014).","journal-title":"Circ. Res."},{"key":"243_CR68","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1161\/HYPERTENSIONAHA.113.02883","volume":"63","author":"CA Amador","year":"2014","unstructured":"Amador, C. A. et al. Spironolactone decreases DOCA-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes. Hypertension 63, 797\u2013803 (2014).","journal-title":"Hypertension"},{"key":"243_CR69","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.atherosclerosis.2011.12.026","volume":"221","author":"Z Liu","year":"2012","unstructured":"Liu, Z. et al. Correlation of peripheral Th17 cells and Th17-associated cytokines to the severity of carotid artery plaque and its clinical implication. Atherosclerosis 221, 232\u2013241 (2012).","journal-title":"Atherosclerosis"},{"key":"243_CR70","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00395-010-0135-y","volume":"106","author":"C Erbel","year":"2011","unstructured":"Erbel, C. et al. Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability. Basic Res. Cardiol. 106, 125\u2013134 (2011).","journal-title":"Basic Res. Cardiol."},{"key":"243_CR71","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1097\/01.mca.0000236288.94553.b4","volume":"17","author":"S Hashmi","year":"2006","unstructured":"Hashmi, S. & Zeng, Q. T. Role of interleukin-17 and interleukin-17-induced cytokines interleukin-6 and interleukin-8 in unstable coronary artery disease. Coron. Artery Dis. 17, 699\u2013706 (2006).","journal-title":"Coron. Artery Dis."},{"key":"243_CR72","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.clim.2008.01.009","volume":"127","author":"X Cheng","year":"2008","unstructured":"Cheng, X. et al. The Th17\/Treg imbalance in patients with acute coronary syndrome. Clin. Immunol. 127, 89\u201397 (2008).","journal-title":"Clin. Immunol."},{"key":"243_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188202","volume":"12","author":"T Bochaton","year":"2017","unstructured":"Bochaton, T. et al. Early kinetics of serum Interleukine-17A and infarct size in patients with reperfused acute ST-elevated myocardial infarction. PLOS ONE 12, e0188202 (2017).","journal-title":"PLOS ONE"},{"key":"243_CR74","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1093\/eurheartj\/ehs263","volume":"34","author":"T Simon","year":"2013","unstructured":"Simon, T. et al. Circulating levels of interleukin-17 and cardiovascular outcomes in patients with acute myocardial infarction. Eur. Heart J. 34, 570\u2013577 (2013).","journal-title":"Eur. Heart J."},{"key":"243_CR75","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","volume":"296","author":"JM Gelfand","year":"2006","unstructured":"Gelfand, J. M. et al. Risk of myocardial infarction in patients with psoriasis. JAMA 296, 1735\u20131741 (2006).","journal-title":"JAMA"},{"key":"243_CR76","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1038\/jid.2009.112","volume":"129","author":"JM Gelfand","year":"2009","unstructured":"Gelfand, J. M. et al. The risk of stroke in patients with psoriasis. J. Invest. Dermatol. 129, 2411\u20132418 (2009).","journal-title":"J. Invest. Dermatol."},{"key":"243_CR77","doi-asserted-by":"publisher","first-page":"7473","DOI":"10.1007\/s11033-012-1580-5","volume":"39","author":"H-S Ding","year":"2012","unstructured":"Ding, H.-S. et al. Interleukin-17 contributes to cardiovascular diseases. Mol. Biol. Rep. 39, 7473\u20137478 (2012).","journal-title":"Mol. Biol. Rep."},{"key":"243_CR78","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/exd.13467","volume":"27","author":"JG Krueger","year":"2018","unstructured":"Krueger, J. G. & Brunner, P. M. Interleukin-17 alters the biology of many cell types involved in the genesis of psoriasis, systemic inflammation and associated comorbidities. Exp. Dermatol. 27, 115\u2013123 (2018).","journal-title":"Exp. Dermatol."},{"key":"243_CR79","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.autrev.2018.06.008","volume":"17","author":"A Beringer","year":"2018","unstructured":"Beringer, A. & Miossec, P. IL-17 and IL-17-producing cells and liver diseases, with focus on autoimmune liver diseases. Autoimmun. Rev. 17, 1176\u20131185 (2018).","journal-title":"Autoimmun. Rev."},{"key":"243_CR80","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/cmi.2010.5","volume":"7","author":"F Lafdil","year":"2010","unstructured":"Lafdil, F., Miller, A. M., Ki, S. H. & Gao, B. Th17 cells and their associated cytokines in liver diseases. Cell. Mol. Immunol. 7, 250\u2013254 (2010).","journal-title":"Cell. Mol. Immunol."},{"key":"243_CR81","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/hep.22680","volume":"49","author":"A Lemmers","year":"2009","unstructured":"Lemmers, A. et al. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology 49, 646\u2013657 (2009).","journal-title":"Hepatology"},{"key":"243_CR82","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1053\/j.gastro.2012.05.049","volume":"143","author":"F Meng","year":"2012","unstructured":"Meng, F. et al. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology 143, 765\u2013776 (2012).","journal-title":"Gastroenterology"},{"key":"243_CR83","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/cei.13140","volume":"193","author":"A Beringer","year":"2018","unstructured":"Beringer, A., Thiam, N., Molle, J., Bartosch, B. & Miossec, P. Synergistic effect of interleukin-17 and tumour necrosis factor-\u03b1 on inflammatory response in hepatocytes through interleukin-6-dependent and independent pathways. Clin. Exp. Immunol. 193, 221\u2013233 (2018).","journal-title":"Clin. Exp. Immunol."},{"key":"243_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-10-150","volume":"10","author":"F-M Gu","year":"2011","unstructured":"Gu, F.-M. et al. IL-17 induces AKT-dependent IL-6\/JAK2\/STAT3 activation and tumor progression in hepatocellular carcinoma. Mol. Cancer 10, 150 (2011).","journal-title":"Mol. Cancer"},{"key":"243_CR85","doi-asserted-by":"publisher","first-page":"27229","DOI":"10.1074\/jbc.M703250200","volume":"282","author":"DN Patel","year":"2007","unstructured":"Patel, D. N. et al. Interleukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1\/2-dependent NF-kappaB and C\/EBPbeta activation. J. Biol. Chem. 282, 27229\u201327238 (2007).","journal-title":"J. Biol. Chem."},{"key":"243_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018909","volume":"6","author":"L Zhao","year":"2011","unstructured":"Zhao, L. et al. Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression. PLOS ONE 6, e18909 (2011).","journal-title":"PLOS ONE"},{"key":"243_CR87","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1056\/NEJMoa040967","volume":"351","author":"JK Pai","year":"2004","unstructured":"Pai, J. K. et al. Inflammatory markers and the risk of coronary heart disease in men and women. N. Engl. J. Med. 351, 2599\u20132610 (2004).","journal-title":"N. Engl. J. Med."},{"key":"243_CR88","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.4049\/jimmunol.1203013","volume":"191","author":"Z Tan","year":"2013","unstructured":"Tan, Z. et al. IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation. J. Immunol. 191, 1835\u20131844 (2013).","journal-title":"J. Immunol."},{"key":"243_CR89","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1365-2893.2011.01561.x","volume":"19","author":"HQ Sun","year":"2012","unstructured":"Sun, H. Q. et al. Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosis. J. Viral Hepat. 19, 396\u2013403 (2012).","journal-title":"J. Viral Hepat."},{"key":"243_CR90","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1365-2249.2009.03947.x","volume":"157","author":"K Harada","year":"2009","unstructured":"Harada, K. et al. Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis. Clin. Exp. Immunol. 157, 261\u2013270 (2009).","journal-title":"Clin. Exp. Immunol."},{"key":"243_CR91","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001888","volume":"94","author":"T Shi","year":"2015","unstructured":"Shi, T. et al. The distribution and the fibrotic role of elevated inflammatory Th17 cells in patients with primary biliary cirrhosis. Medicine (Baltimore) 94, e1888 (2015).","journal-title":"Medicine (Baltimore)"},{"key":"243_CR92","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.4049\/jimmunol.1400861","volume":"193","author":"T Fabre","year":"2014","unstructured":"Fabre, T., Kared, H., Friedman, S. L. & Shoukry, N. H. IL-17A enhances the expression of profibrotic genes through upregulation of the TGF-\u03b2 receptor on hepatic stellate cells in a JNK-dependent manner. J. Immunol. 193, 3925\u20133933 (2014).","journal-title":"J. Immunol."},{"key":"243_CR93","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.molimm.2014.10.021","volume":"64","author":"S Amara","year":"2015","unstructured":"Amara, S. et al. Synergistic effect of pro-inflammatory TNF\u03b1 and IL-17 in periostin mediated collagen deposition: potential role in liver fibrosis. Mol. Immunol. 64, 26\u201335 (2015).","journal-title":"Mol. Immunol."},{"key":"243_CR94","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1053\/j.gastro.2009.08.004","volume":"137","author":"F Lafdil","year":"2009","unstructured":"Lafdil, F. et al. Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production. Gastroenterology 137, 2125\u20132135 (2009).","journal-title":"Gastroenterology"},{"key":"243_CR95","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s10875-012-9840-7","volume":"33","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y. et al. MicroRNA let-7a ameliorates Con A-induced hepatitis by inhibiting IL-6-dependent Th17 cell differentiation. J. Clin. Immunol. 33, 630\u2013639 (2013).","journal-title":"J. Clin. Immunol."},{"key":"243_CR96","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1002\/eji.201141291","volume":"41","author":"M Xu","year":"2011","unstructured":"Xu, M. et al. Regulation of the development of acute hepatitis by IL-23 through IL-22 and IL-17 production. Eur. J. Immunol. 41, 2828\u20132839 (2011).","journal-title":"Eur. J. Immunol."},{"key":"243_CR97","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/icb.2011.59","volume":"90","author":"S Yan","year":"2012","unstructured":"Yan, S., Wang, L., Liu, N., Wang, Y. & Chu, Y. Critical role of interleukin-17\/interleukin-17 receptor axis in mediating Con A-induced hepatitis. Immunol. Cell Biol. 90, 421\u2013428 (2012).","journal-title":"Immunol. Cell Biol."},{"key":"243_CR98","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073909","volume":"8","author":"J He","year":"2013","unstructured":"He, J., Lang, G., Ding, S. & Li, L. Pathological role of interleukin-17 in poly I:C-induced hepatitis. PLOS ONE 8, e73909 (2013).","journal-title":"PLOS ONE"},{"key":"243_CR99","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.jss.2015.05.060","volume":"199","author":"S Furuya","year":"2015","unstructured":"Furuya, S. et al. Interleukin 17A plays a role in lipopolysaccharide\/D-galactosamine-induced fulminant hepatic injury in mice. J. Surg. Res. 199, 487\u2013493 (2015).","journal-title":"J. Surg. Res."},{"key":"243_CR100","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s11596-010-0446-0","volume":"30","author":"H Yu","year":"2010","unstructured":"Yu, H. et al. IL-17 contributes to autoimmune hepatitis. J. Huazhong Univ. Sci. Technol. Med. Sci. 30, 443\u2013446 (2010).","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"243_CR101","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074225","volume":"8","author":"K Kawata","year":"2013","unstructured":"Kawata, K. et al. Identification of potential cytokine pathways for therapeutic intervention in murine primary biliary cirrhosis. PLOS ONE 8, e74225 (2013).","journal-title":"PLOS ONE"},{"key":"243_CR102","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1111\/bjd.15220","volume":"176","author":"EAM van der Voort","year":"2017","unstructured":"van der Voort, E. A. M., Wakkee, M., Veldt-Kok, P., Darwish Murad, S. & Nijsten, T. Enhanced liver fibrosis test in patients with psoriasis, psoriatic arthritis and rheumatoid arthritis: a cross-sectional comparison with procollagen-3 N-terminal peptide (P3NP). Br. J. Dermatol. 176, 1599\u20131606 (2017).","journal-title":"Br. J. Dermatol."},{"key":"243_CR103","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.jid.2017.10.024","volume":"138","author":"A Ogdie","year":"2018","unstructured":"Ogdie, A. et al. Risk of incident liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis: a population-based study. J. Invest. Dermatol. 138, 760\u2013767 (2018).","journal-title":"J. Invest. Dermatol."},{"key":"243_CR104","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/rheumatology\/36.2.210","volume":"36","author":"EM Ruderman","year":"1997","unstructured":"Ruderman, E. M. et al. Histologic liver abnormalities in an autopsy series of patients with rheumatoid arthritis. Br. J. Rheumatol. 36, 210\u2013213 (1997).","journal-title":"Br. J. Rheumatol."},{"key":"243_CR105","doi-asserted-by":"publisher","first-page":"R143","DOI":"10.1186\/ar3085","volume":"12","author":"E Quintin","year":"2010","unstructured":"Quintin, E., Scoazec, J.-Y., Marotte, H. & Miossec, P. Rare incidence of methotrexate-specific lesions in liver biopsy of patients with arthritis and elevated liver enzymes. Arthritis Res. Ther. 12, R143 (2010).","journal-title":"Arthritis Res. Ther."},{"key":"243_CR106","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1136\/annrheumdis-2011-200830","volume":"71","author":"G Toulemonde","year":"2012","unstructured":"Toulemonde, G., Scoazec, J.-Y. & Miossec, P. Treatment with etanercept of autoimmune hepatitis associated with rheumatoid arthritis: an open label proof of concept study. Ann. Rheum. Dis. 71, 1423\u20131424 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"243_CR107","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.2174\/1389450116666150531153627","volume":"16","author":"DA Giles","year":"2015","unstructured":"Giles, D. A., Moreno-Fernandez, M. E. & Divanovic, S. IL-17 axis driven inflammation in non-alcoholic fatty liver disease progression. Curr. Drug Targets 16, 1315\u20131323 (2015).","journal-title":"Curr. Drug Targets"},{"key":"243_CR108","doi-asserted-by":"publisher","first-page":"9096","DOI":"10.3748\/wjg.v22.i41.9096","volume":"22","author":"CM Chackelevicius","year":"2016","unstructured":"Chackelevicius, C. M., Gambaro, S. E., Tiribelli, C. & Rosso, N. Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis. World J. Gastroenterol. 22, 9096\u20139103 (2016).","journal-title":"World J. Gastroenterol."},{"key":"243_CR109","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0165-5728(03)00032-8","volume":"137","author":"G Chevrel","year":"2003","unstructured":"Chevrel, G. et al. Interleukin-17 increases the effects of IL-1 beta on muscle cells: arguments for the role of T cells in the pathogenesis of myositis. J. Neuroimmunol. 137, 125\u2013133 (2003).","journal-title":"J. Neuroimmunol."},{"key":"243_CR110","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1002\/art.27465","volume":"62","author":"A Tournadre","year":"2010","unstructured":"Tournadre, A., Lenief, V. & Miossec, P. Expression of Toll-like receptor 3 and Toll-like receptor 7 in muscle is characteristic of inflammatory myopathy and is differentially regulated by Th1 and Th17 cytokines. Arthritis Rheum. 62, 2144\u20132151 (2010).","journal-title":"Arthritis Rheum."},{"key":"243_CR111","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.3389\/fimmu.2018.03170","volume":"9","author":"A Beringer","year":"2019","unstructured":"Beringer, A., Gouriou, Y., Lavocat, F., Michel, O. & Miossec, P. Blockade of store-operated calcium entry reduces IL-17\/TNF cytokine-induced inflammatory response in human myoblasts. Front. Immunol. 9, 3170 (2019).","journal-title":"Front. Immunol."},{"key":"243_CR112","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.bbamcr.2012.01.001","volume":"1823","author":"J Kocic\u00b4","year":"2012","unstructured":"Koci\u0107, J. et al. Interleukin 17 inhibits myogenic and promotes osteogenic differentiation of C2C12 myoblasts by activating ERK1,2. Biochim. Biophys. Acta 1823, 838\u2013849 (2012).","journal-title":"Biochim. Biophys. Acta"},{"key":"243_CR113","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.biocel.2012.11.010","volume":"45","author":"J Kocic\u00b4","year":"2013","unstructured":"Koci\u0107, J. et al. Interleukin-17 modulates myoblast cell migration by inhibiting urokinase type plasminogen activator expression through p38 mitogen-activated protein kinase. Int. J. Biochem. Cell Biol. 45, 464\u2013475 (2013).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"243_CR114","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1016\/j.bbamcr.2016.08.013","volume":"1863","author":"S-A Su","year":"2016","unstructured":"Su, S.-A. et al. Interleukin-17A mediates cardiomyocyte apoptosis through Stat3-iNOS pathway. Biochim. Biophys. Acta 1863, 2784\u20132794 (2016).","journal-title":"Biochim. Biophys. Acta"},{"key":"243_CR115","doi-asserted-by":"publisher","first-page":"C1799","DOI":"10.1152\/ajpcell.00166.2006","volume":"292","author":"WA LaFramboise","year":"2007","unstructured":"LaFramboise, W. A. et al. Cardiac fibroblasts influence cardiomyocyte phenotype in vitro. Am. J. Physiol. Cell Physiol. 292, C1799\u2013C1808 (2007).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"243_CR116","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1084\/jem.20132126","volume":"211","author":"L Wu","year":"2014","unstructured":"Wu, L. et al. Cardiac fibroblasts mediate IL-17A-driven inflammatory dilated cardiomyopathy. J. Exp. Med. 211, 1449\u20131464 (2014).","journal-title":"J. Exp. Med."},{"key":"243_CR117","doi-asserted-by":"publisher","first-page":"H3356","DOI":"10.1152\/ajpheart.00928.2007","volume":"293","author":"DM Cortez","year":"2007","unstructured":"Cortez, D. M. et al. IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1\/2-dependent C\/EBP-beta, NF-kappaB, and AP-1 activation. Am. J. Physiol. Heart Circ. Physiol. 293, H3356\u2013H3365 (2007).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"243_CR118","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.cellsig.2011.10.010","volume":"24","author":"AJ Valente","year":"2012","unstructured":"Valente, A. J. et al. Interleukin-17A stimulates cardiac fibroblast proliferation and migration via negative regulation of the dual-specificity phosphatase MKP-1\/DUSP-1. Cell. Signal. 24, 560\u2013568 (2012).","journal-title":"Cell. Signal."},{"key":"243_CR119","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1096\/fj.11-183236","volume":"25","author":"G Atefi","year":"2011","unstructured":"Atefi, G. et al. Complement dependency of cardiomyocyte release of mediators during sepsis. FASEB J. 25, 2500\u20132508 (2011).","journal-title":"FASEB J."},{"key":"243_CR120","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1161\/01.CIR.0000156469.96135.0D","volume":"111","author":"SPM Janssen","year":"2005","unstructured":"Janssen, S. P. M. et al. Interleukin-6 causes myocardial failure and skeletal muscle atrophy in rats. Circulation 111, 996\u20131005 (2005).","journal-title":"Circulation"},{"key":"243_CR121","first-page":"1717","volume":"38","author":"PE Lazzerini","year":"2017","unstructured":"Lazzerini, P. E., Capecchi, P. L. & Laghi-Pasini, F. Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis. Eur. Heart J. 38, 1717\u20131727 (2017).","journal-title":"Eur. Heart J."},{"key":"243_CR122","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/acr.23775","volume":"71","author":"BY Hanaoka","year":"2019","unstructured":"Hanaoka, B. Y. et al. Chronic inflammation in RA: mediator of skeletal muscle pathology and physical impairment. Arthritis Care Res. 71, 173\u2013177 (2019).","journal-title":"Arthritis Care Res."},{"key":"243_CR123","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13075-016-1215-7","volume":"19","author":"KM Huffman","year":"2017","unstructured":"Huffman, K. M. et al. Molecular alterations in skeletal muscle in rheumatoid arthritis are related to disease activity, physical inactivity, and disability. Arthritis Res. Ther. 19, 12 (2017).","journal-title":"Arthritis Res. Ther."},{"key":"243_CR124","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ebiom.2017.07.023","volume":"23","author":"T Yamada","year":"2017","unstructured":"Yamada, T., Steinz, M. M., Kenne, E. & Lanner, J. T. Muscle weakness in rheumatoid arthritis: the role of Ca2+ and free radical signaling. EBioMedicine 23, 12\u201319 (2017).","journal-title":"EBioMedicine"},{"key":"243_CR125","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3899\/jrheum.140831","volume":"43","author":"MC Genovese","year":"2016","unstructured":"Genovese, M. C. et al. Safety and efficacy of open-label subcutaneous ixekizumab treatment for 48 weeks in a phase II study in biologic-naive and TNF-IR patients with rheumatoid arthritis. J. Rheumatol. 43, 289\u2013297 (2016).","journal-title":"J. Rheumatol."},{"key":"243_CR126","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/art.40070","volume":"69","author":"FJ Blanco","year":"2017","unstructured":"Blanco, F. J. et al. Secukinumab in active rheumatoid arthritis: a phase III randomized, double-blind, active comparator- and placebo-controlled study. Arthritis Rheumatol. 69, 1144\u20131153 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"243_CR127","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s00296-016-3480-9","volume":"36","author":"S Kunwar","year":"2016","unstructured":"Kunwar, S., Dahal, K. & Sharma, S. Anti-IL-17 therapy in treatment of rheumatoid arthritis: a systematic literature review and meta-analysis of randomized controlled trials. Rheumatol. Int. 36, 1065\u20131075 (2016).","journal-title":"Rheumatol. Int."},{"key":"243_CR128","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.ajpath.2013.07.019","volume":"183","author":"KM O\u2019Brien","year":"2013","unstructured":"O\u2019Brien, K. M. et al. IL-17A synergistically enhances bile acid\u2013induced inflammation during obstructive cholestasis. Am. J. Pathol. 183, 1498\u20131507 (2013).","journal-title":"Am. J. Pathol."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41584-019-0243-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41584-019-0243-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41584-019-0243-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T02:44:24Z","timestamp":1721443464000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-019-0243-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,21]]},"references-count":128,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["243"],"URL":"https:\/\/doi.org\/10.1038\/s41584-019-0243-5","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,21]]},"assertion":[{"value":"21 May 2019","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.M. holds a patent on the IL-17 bioassay (patent number 20170176456). A.B. declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}